Stocktoria

Celltrion, Inc. 068270.KS

KR · Korea Exchange · XKRX · stock · Healthcare · website

Celltrion, Inc. statistics & valuation

Market cap₩40.02T
P / E38.9×
P / S9.6×
P / B2.3×
P / FCF127.3×
Net margin24.7%
FCF margin7.6%
Net debt₩2.61T
Enterprise value USD$25.6B

Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
2022202320242025
Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
2022202320242025
Net debt (₩)
2022202320242025
Share buybacks (₩)
2022202320242025
Return on assets (%)
2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS (₩)
2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Celltrion, Inc. trades at about 39.3× earnings — below its 10-year norm (10-year range 47.3×–104.6×, median 54.9×).

39.3× 104.6×

Shaded band = 10-year range (47.3×–104.6×); dot = today's 39.3×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin59.3%47.3%48.3%45.2%
Operating margin27.8%13.8%29.9%28.3%
Net margin24.7%11.9%24.6%23.5%
FCF margin7.6%16.0%8.4%-13.6%
Return on assets4.6%2.0%2.7%9.1%
Return on equity6.0%2.4%3.2%13.0%
Debt / equity0.02×0.00×0.01×0.04×
Current ratio1.391.752.032.26

Computed from company filings · KR · as of 2025-12-31. Figures in KRW. Facts plus Stocktoria's own computed scores — not investment advice.